Life sciences lead US venture investments

Biotech and medical device deals represented 32 percent of investments during the first quarter, which saw an approximate 5 percent drop in investment dollars from the same period in 2007.

To view this content, you need to sign in.


You should only be asked to sign in once. Not the case? Click here


Register now to access this content and more for free.

Share this